Food & Beverage Recalls
ALB-USA Enterprises Recalls ALB Flavor Ground Cinnamon Because of Possible Health Risk
ALB-USA Enterprises, Inc. of Bronx, NY is recalling ALB Flavor brand Cinnamon Powder, because it potentially contaminated with elevated levels of lead. Short-term exposures to very low levels of lead may not elicit any symptoms. It is possible that increased blood lead levels may be the only apparent sign of lead exposure. Additional signs and symptoms of lead exposure are more likely to be acute exposure to higher levels of lead or chronic exposure to lead. While lead can affect nearly every bodily system, its effects depend upon the amount and duration of lead exposure and age/ body weight. If a child is exposed to enough lead for a protracted period of time (e.g., weeks to months) permanent damage to the central nervous system may occur. This can result in learning disorders, developmental defects, and other long-term health problems. For adults, chronic lead exposure is associated with kidney dysfunction, hypertension, and neurocognitive effects.
ALB Flavor brand Ground Cinnamon was distributed to retailers located in New York, Connecticut, Michigan, and Massachusetts, between 12/15/2022 and 05/13/2024.
In Association with Wiers Farm, Inc. and R.S. Hanline Co Inc., ALDI Recalls Jalapenos, Green Peppers and Green Beans Due to a Potential Listeria Monocytogenes Contamination
Batavia, Ill. (July 22, 2024) – In cooperation with Wiers Farm, Inc. and R.S. Hanline Co Inc. and out of an abundance of caution, ALDI Inc., (“ALDI”) recalls Freshire Farms jalapenos, green peppers and green beans. The affected product from Wiers Farm, Inc. and R.S. Hanline Co Inc is recalled due to a potential listeria monocytogenes contamination. The full product details include:
Jalapeno 8 oz. bag 4099100087680
Green Pepper 16 oz. (3 pack) bag 4099100087598
Green Beans 16 oz. bag 4099100087826
The affected product was sold at select ALDI stores in Kentucky, New York, Ohio, Pennsylvania and West Virginia.
JFE Franchising, Inc. Recalls A Limited Number of Products Because Of Possible Health Risk
Houston, TX (July 25, 2024) – JFE Franchising, Inc. of Houston, TX, is recalling a limited number of products because they may be contaminated with Listeria monocytogenes.
Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. There have been no illnesses or consumer complaints reported to date.
Kenny’s Farmhouse Cheese Recalls St. Jerome Cheese Lot: 231129 Because of Possible Health Risk
Kenny’s Farmhouse Cheese of Austin, Ky is recalling St. Jerome cheese, batch 231129, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
The recalled St. Jerome cheese was distributed via wholesale customers, retail storefront, and through Kenny’s Farmhouse Cheese website https://kennyscheese.comExternal Link Disclaimer.
Wiers Farm, Inc Expands Voluntary Recall on Whole and Salad Cucumbers Due to Possible Contamination with Listeria
FOR IMMEDIATE RELEASE: Additional produce has been added to the original recall as indicated below.
Willard, OH (July 22, 2024) - Out of an abundance of caution, Wiers Farm Inc. of Willard, OH, is expanding its July 12, 2024, recall to include additional produce because it may be contaminated with Listeria monocytogenes. Wiers Farm Inc., in cooperation with the Ohio Department of Agriculture (ODA), began its investigation in response to original findings reported by the Michigan Department of Agriculture (MDARD). This expansion is in response to that investigation. Products involved in this expanded recall were packed between July 5-12 (2024). Wiers Farm Inc. is committed to implementing all measures necessary to fully resolve this situation.
There have been no illnesses or consumer complaints reported to date.
Wiers Farm, Inc Expands Voluntary Recall on Whole and Salad Cucumbers Due to Possible Contamination with Listeria
Stutz Packing Company of Indio, CA is voluntarily recalling it’s 1-pound packages of Shelled Walnuts, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
These Walnuts were distributed to food bank warehouses in Texas and Arizona which further distribute to other distribution centers that can go to consumers, or smaller foods banks, school lunch programs, shelters, or prison food systems.utz Packing Co. Recalls Walnut Product Because of Possible Health Risk
Dietary Supplements & Drugs Recalls
Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Voluntary Nationwide Recall of one (1) Lot of Healthy Living Over the Counter (OTC) Migraine Relief: Acetaminophen 250mg; Aspirin 250mg; Caffeine 65mg Tablets, Due to Missing Manufacturer Label
Aurobindo Pharma USA, Inc.: Contact 1-866-850-2876 (Option 2)
Recall being handled by Qualanex: Contact 1-888-504-2014
FOR IMMEDIATE RELEASE – July 18, 2024 – East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief, Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets, to the consumer level as sold through Amazon to known within the US market due to the product missing the manufacturer label.
NDC No. Product Name, strength, and pack Lot number Expiry
58602-882-21 Acetaminophen 250mg; Aspirin 250mg;
Caffeine 65mg tablets – 100ct bottles AC2523005A June-2025
Risk Statement: Amazon customers having purchased the above product will have a white unlabeled bottle from the Manufacturer (AuroHealth) bearing only an Amazon identifying sticker, as shown below. As a result, the product lacks the required Over the Counter (OTC) labeling information, drug facts and patient usage information. There is significant risk of misuse which could result in permanent liver damage if consumers exceed the recommended dose, combine use with excessive consumption of alcohol or are allergic to the active ingredient which could be life-threatening. To date, Aurobindo has not received any reports of adverse drug events that are confirmed related to this recall.
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL, (10mg/mL) Bags Due to an Individual Unit of Acetaminophen Overwrap Found to Have Contained a Labelled Bag of Dexmedetomidine HCL Injection (400mcg/100mL)
FOR IMMEDIATE RELEASE - London, July 22, 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA, Inc. is extending its voluntary recall of one lot (listed below) of Acetaminophen Injection, 1000mg/100mL, (10mg/mL) to the consumer/user level. The product is being recalled due to the potential presence of a bag labelled Dexmedetomidine HCL Injection (400mcg/100mL) inside the overwrap that is labelled Acetaminophen Injection, 1000mg/100mL, (10mg/mL).
If the provider does not identify the drug inside the acetaminophen overwrap as dexmedetomidine and administers the drug to a patient, there are multiple potential adverse outcomes that may result including varying degrees of sedation, bradypnea, bradycardia, hypertension, and hypotension or more serious and potentially life-threatening outcomes. To date, Hikma has received one report of an adverse event.
On July 8, 2024, Hikma voluntarily initiated a retail level recall of Acetaminophen Injection 1000mg/100mL(10mg/mL), lot 24070381.
Main Products, Inc. Issues Voluntary Nationwide Recall of Umary Acido Hialuronico, Suplemento Alimenticio Due to the Presence of Undeclared Drug Ingredients: Diclofenac and Omeprazole
FOR IMMEDIATE RELEASE – 07/22/2024 – Chula Vista, CA – Main Products, Inc. is voluntarily recalling all lots of “Umary Acido Hialuronico, Suplemento Alimenticio – 30 Capletas de 850mg” to the consumer level. FDA laboratory analysis confirmed that UMARY has been found to be tainted with the drug ingredients, diclofenac and omeprazole. Products containing diclofenac and omeprazole cannot be marketed as dietary supplements. Umary is an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.
Risk Statement: Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). There is a reasonable probability that consumption of high levels of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses.
Read Comments